Tianjin Finder Chemical: difference between revisions
Diff·revision 6 → 7·01:07, 24 Dec 2024
Difference between revision 6 and revision 7 of Tianjin Finder Chemical. 4 lines changed; the page grew by 671 bytes.
| Revision 6 — 17:07, 15 Dec 2024 ReportReaderRilla (talk) expand §Notability and coverage 4,570 bytes +798 | Revision 7 — 01:07, 24 Dec 2024 Areapercent_Ayo (talk) ce 5,241 bytes +671 | ||
|---|---|---|---|
| 28 | Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance; water determinations and method statements are issued against a named lot on request.{{r|reports}} Packaging descriptions have been consistent between orders across the submitted set. | 28 | Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance; water determinations and method statements are issued against a named lot on request.{{r|reports}} Packaging descriptions have been consistent between orders across the submitted set. |
| 29 | 29 | ||
| + | 30 | Tianjin's port position appears in reports as relatively short and predictable transit, and reported customs handling has been unremarkable.{{r|reports}} Origin has been consistently described as China rather than a regional warehouse, which means the certificate date and the dispatch date have generally been close — a fact worth having when reading a purity figure, because it narrows the interval over which anything could have changed.{{r|usp1503}} | |
| + | 31 | ||
| 30 | == References == | 32 | == References == |
| 31 | {{reflist}} | 33 | {{reflist}} |
| ⋮ | ⋮ | ||
| 34 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 36 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| 35 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 37 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| + | 38 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | |
| 36 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 39 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 37 | 40 | ||
| ⋮ | ⋮ | ||
| 40 | [[Category:Suppliers in China]] | 43 | [[Category:Suppliers in China]] |
| 41 | [[Category:Certificates of analysis]] | 44 | [[Category:Certificates of analysis]] |
| + | 45 | [[Category:Testing methodology]] | |
| 42 | 46 |